Last Updated: 18/06/2024

Development of selective threonyl-tRNA inhibitors of malaria

Objectives

This project aims at the development of selective threonyl-tRNA inhibitors of malaria.

Principal Institution

Latvian Institute of Organic Synthesis (OSI), Latvia

Principal Investigators / Focal Persons

Aigars Jirgensons

External reference

Project details

Themes

Product Development

Date

Oct 2020 — Sep 2023

Total Project Funding

$737,687

Funding Details
Ministry of Education and Science (MoES) Latvia, Latvia

Grant ID: 1.1.1.1/19/A/019
EUR 648,646
Project Site

Latvia

SHARE

Related Resources

Practical guide for the development of consolidated national infection prevention and control guidelines
Guidance & Strategy
Introduction to Small Molecule Drug Discovery & Development
Training
Practical Guidance for the Development of National Essential Diagnostics Lists
Guidance & Strategy

Related Projects

Apr 2022 —
Mar 2025

$21,031

Development of malaria-selective covalent inhibitors targeting serine-metabolizing enzymes
University of Tokyo, Japan
Aug 2022 —
Aug 2025

$66,790

Biocatalytic enantioselective synthesis of non-biaryl and hetero-biaryl atropisomers and testing of their antimalarial properties
University of Michigan (UMich), United States
SHARE